Strategies for the Management of Intraprocedural Thromboembolic Complications with Abciximab (ReoPro)

Abstract

Abciximab (ReoPro), administered either intravenously or intra-arterially, is a viable option for the management of thromboembolic complications encountered during endovascular therapeutic procedures.